Hong Kong’s IPO market posted a hefty haul in 2026, with issuers raising more than HK$140 billion—roughly $17.9 billion—through the first eleven months. The figure, disclosed in a weekly blog post, reaffirms the city’s status as the world’s leading primary equity venue. Investor appetite remained strong despite regional volatility, and several high‑profile tech and biotech firms topped the list of debutants.

The surge reflects a rebound after a subdued 2025 cycle, when tightening capital controls in mainland China dampened cross‑border listings. Hong Kong’s regulatory tweaks, including streamlined approval for dual‑class shares, have attracted issuers seeking a gateway to Asian capital, bolstering the market’s depth and delivering higher average pricing for new shares.

Among the top contributors, a state‑backed fintech platform and a renewable‑energy consortium each secured over HK$20 billion in proceeds, signaling investor confidence in sectors aligned with China’s strategic priorities. Their listings also expanded the pool of Hong Kong‑listed securities available to global funds, enhancing portfolio diversification for institutional investors.

Financial Secretary Paul Chan credited the results to coordinated efforts between the Securities and Futures Commission and the Stock Exchange, which have streamlined filing processes and reinforced market integrity. The robust fundraising tally underscores Hong Kong’s continued appeal as a premier venue for large‑scale capital raises.